CFLAR and breast neoplasm: Moreover, Yerbes and Lόpez-Rivas also reported that a histone deacetylase inhibitor suberoylanilide hydroxamic acid induced the Itch-independent proteasomal degradation of both cFLIPL and cFLIPS and sensitized breast tumor cells to TRAIL [72].